Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Acme Formulation Private Limited, is an unlisted private company incorporated on 21 June, 2004. It is classified as a private limited company and is located in Himachal Pradesh, Himachal Pradesh. It's authorized share capital is INR 18.00 cr and the total paid-up capital is INR 7.25 cr.
Acme Formulation's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 85.74% over the previous year. At the same time, it's book networth has increased by 4.73%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
-17.43%
-22.78%
1.35%
4.6%
-26.17%
2.93%
5.97
-0.85
2.23
-0.14
0.88
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 3
Total Amount : 65.0 cr
State Bank of India
No. of Loans: 1
Total Amount : 50.7 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| CEO | Viral Shah
Shareholder
|
01079170 | 18 years |
| Kmp | Viral Shah | <HIDDEN> | 3 years |
| Director | Nikhil Kumar Srivastava | 07308617 | 3 years |
| Whole-time Director | Vikas Sharma | 08810122 | 4 years |
| Director | Aswin Vikram | 08895013 | 3 years |
| Kmp | Ginny Uppal | <HIDDEN> | 0 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| ACE INVEST PRIVATE LIMITED |
Active
|
24.6 Cr | 2 | Chandigarh |
| ACE LIFESCIENCE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Gujarat |
| TEKNO TOUCH PRIVATE LIMITED |
Active
|
1.0 L | 1 | Gujarat |
| ACE TESTING SOLUTIONS PRIVATE LIMITED |
Active
|
1,611.0 | 2 | Himachal Pradesh |
| ACE FORMULATIONS LLP |
Defunct
|
5.0 L | 1 | Chandigarh |
| ACME GENERICS LLP |
Converted to CMP and Dissolved
|
113.9 Cr | 1 | Chandigarh |
| AMBRIEL LIFE SCIENCES LLP |
Active
|
10.0 L | 1 | Chandigarh |
| ACME GENERICS PRIVATE LIMITED |
Active
|
120.1 Cr | 3 | Punjab |
| IMMACULE LIFESCIENCES PRIVATE LIMITED |
Active
|
105.1 Cr | 4 | Himachal Pradesh |
| RADIANT LIFE CARE PRIVATE LIMITED |
Amalgamated
|
14.7 Cr | 1 | Maharashtra |
| NUVAMA WEALTH MANAGEMENT LIMITED |
Active
|
35.3 Cr | 2 | Maharashtra |
| PAGAC ADVISORS INDIA PRIVATE LIMITED |
Active
|
29.7 L | 2 | Maharashtra |
| SEKHMET PHARMAVENTURES PRIVATE LIMITED |
Active
|
1,817.3 Cr | 2 | Maharashtra |
| NUVAMA WEALTH FINANCE LIMITED |
Active
|
11.5 Cr | 1 | Maharashtra |
| NUVAMA WEALTH MANAGEMENT LIMITED |
Active
|
35.3 Cr | 2 | Maharashtra |
| NOVAAIR PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| NOVAAIR TECHNOLOGIES PRIVATE LIMITED |
Active
|
14.6 Cr | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| ACME GENERICS PRIVATE LIMITED | Punjab | 2021 | ₹ 120.1 Cr |
| IMMACULE LIFESCIENCES PRIVATE LIMITED | Himachal Pradesh | 2010 | ₹ 105.1 Cr |
| ACE INVEST PRIVATE LIMITED | Chandigarh | 2013 | ₹ 24.6 Cr |
| ACE TESTING SOLUTIONS PRIVATE LIMITED | Himachal Pradesh | 2009 | ₹ 1,611.0 |
The incorporation date of ACME FORMULATION PRIVATE LIMITED is 21 June, 2004
The authorized share capital of ACME FORMULATION PRIVATE LIMITED is INR ₹ 18.0 Cr.
The paid-up capital of ACME FORMULATION PRIVATE LIMITED is INR ₹ 7.3 Cr.
The registered address of ACME FORMULATION PRIVATE LIMITED is VILLAGE CHOWKIWALATEHSIL NALAGARH DISTT SOLAN HIMACHAL PRADESH Himachal Pradesh - 000000
The CIN number of ACME FORMULATION PRIVATE LIMITED is U24230HP2004PTC027223.
Expand
Delete
Collapse
See
details
